We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Reverses Pfizer’s Celebrex Patent; Drugmaker Vows to Appeal
Judge Reverses Pfizer’s Celebrex Patent; Drugmaker Vows to Appeal
Pfizer was dealt a heavy blow Mar. 12 after a judge cleared the way for five generic drugmakers to begin making generic versions of Pfizer’s blockbuster osteoarthritis drug Celebrex.